does retatrutide cause cancer GLP-1 weight-loss drugs are transforming lives — but what do they really mean for people facing cancer? We brought together perspectives from researchers, clinicians and patients navigating the promise and the tradeoffs Retatrutide vs Tirzepatide: Which Weight-Loss

Vinik AI, et al

Supplementation strategies designed for GLP-1 users can help maintain nerve health during treatment

From a strictly harm-reduction standpoint, restoring legal compounding access under physician oversight is arguably safer than maintaining a black-market status quo

Additional Findings Blood sugar improvements: People with type 2 diabetes saw big improvements in their long-term blood sugar levels (measured by a test called HbA1c) Liver fat reduction: Participants saw significant reductions in liver fat good news for anyone dealing with fatty liver Heart health markers: Blood pressure, cholesterol, and triglyceride levels all improved Waist circumference: Significant reductions in waist circumference were observed across all dose groups Phase 3 Trials (Ongoing) Eli Lilly has launched the TRIUMPH program a series of larger Phase 3 trials to test Retatrutide in more people and more situations

Its essential to discuss potential side effects with your healthcare provider